The challenge of developmental therapeutics for adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare disease with an estimated incidence of only 0.7 new cases per million per year. Approximately 30-70% of the patients present with advanced disease with very poor prognosis and without effective therapeutic options. In the recent years, unprecedented progresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Ricardo, Carneiro, Benedito A., Tavora, Fabio, Pai, Sachin G., Kaplan, Jason B., Chae, Young Kwang, Chandra, Sunandana, Kopp, Peter A., Giles, Francis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216833/
https://www.ncbi.nlm.nih.gov/pubmed/27102148
http://dx.doi.org/10.18632/oncotarget.8774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216833/
https://www.ncbi.nlm.nih.gov/pubmed/27102148
http://dx.doi.org/10.18632/oncotarget.8774

Ejemplares similares